Avidity Partners Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,100,000
| Closed | -$42.1M | – | 89 |
|
|
2023
Q3 | $42.1M | Sell |
2,100,000
-234,000
| -10% | -$4.69M | 1.7% | 21 |
|
|
2023
Q2 | $65.8M | Sell |
2,334,000
-595,300
| -20% | -$16.8M | 2.3% | 11 |
|
|
2023
Q1 | $50.4M | Sell |
2,929,300
-2,220,700
| -43% | -$38.2M | 1.67% | 24 |
|
|
2022
Q4 | $104M | Buy |
5,150,000
+926,900
| +22% | +$18.7M | 2.25% | 14 |
|
|
2022
Q3 | $91.5M | Buy |
4,223,100
+637,219
| +18% | +$13.8M | 1.86% | 20 |
|
|
2022
Q2 | $101M | Buy |
3,585,881
+408,882
| +13% | +$11.5M | 2.31% | 19 |
|
|
2022
Q1 | $147M | Buy |
3,176,999
+461,999
| +17% | +$21.3M | 3.05% | 8 |
|
|
2021
Q4 | $228M | Buy |
2,715,000
+221,200
| +9% | +$18.6M | 4.84% | 2 |
|
|
2021
Q3 | $166M | Buy |
2,493,800
+333,800
| +15% | +$22.2M | 3.68% | 5 |
|
|
2021
Q2 | $115M | Buy |
2,160,000
+896,700
| +71% | +$47.7M | 3.11% | 7 |
|
|
2021
Q1 | $54.8M | Buy |
1,263,300
+128,300
| +11% | +$5.57M | 1.51% | 22 |
|
|
2020
Q4 | $59M | Buy |
1,135,000
+230,881
| +26% | +$12M | 1.91% | 13 |
|
|
2020
Q3 | $29.6M | Buy |
904,119
+229,632
| +34% | +$7.51M | 1.37% | 22 |
|
|
2020
Q2 | $32.4M | Buy |
+674,487
| New | +$32.4M | 2.08% | 17 |
|